Chongqing establishes a warning system of interview for drug manufacturers
-
Last Update: 2013-08-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, Chongqing food and drug administration has formulated and implemented the "warning system for interview of drug manufacturing enterprises (Trial)", which regulates the object, procedure and content of the warning Chongqing Municipal Bureau has made it clear that in the daily supervision, the drug regulatory authorities have found that there are serious defects in the production and quality management of enterprises and hidden dangers in the quality and safety of drugs; there are signs of violations of laws and regulations on drug production management; there are violations, but the laws and regulations do not provide for corresponding penalties, and administrative penalties cannot be imposed; new and serious adverse reactions of listed products have occurred for many times; the masses have recommended When there are facts reported or reports reported, they are relatively concentrated, and the social response is great; when there are frequent changes in key positions, the company should be interviewed and warned The contents of the interview and warning mainly include pointing out the problems or hidden dangers existing in the pharmaceutical production and quality management of the enterprise and the safety hidden dangers existing in the listed products, at the same time, propagating the relevant laws, regulations and policies on pharmaceutical management to the enterprise, urging the enterprise to organize production and operation according to law, and implementing the responsibilities of the first person responsible for pharmaceutical safety, etc.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.